Department of Urology, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
University of Alabama at Birmingham School of Medicine, Birmingham, Alabama.
J Urol. 2020 Sep;204(3):490-495. doi: 10.1097/JU.0000000000000811. Epub 2020 Feb 24.
Surgical approach to radical prostatectomy has evolved due to advances in minimally invasive surgery, with most contemporary approaches involving the Si or Xi multi-port robotic systems. U.S. Food and Drug Administration approval of the single-port da Vinci® SP robotic platform has led to a few case series suggesting its safety and feasibility for robotic assisted radical prostatectomy in patients with prostate cancer. However, there are no established data on perioperative outcomes comparing single-port to multi-port robotic approaches to robot-assisted radical prostatectomy.
All patients who underwent robot-assisted radical prostatectomy by 2 urological surgeons at our institution between October 2018 and June 2019 were retrospectively reviewed. The available preoperative clinical and demographic data, operative parameters and postoperative outcomes were collected and analyzed using the t-test, chi-square and Fisher exact statistical measures.
Overall 95 patients who underwent robot-assisted radical prostatectomy at our institution were included in our study, with 47 single-port and 48 multi-port. Preoperative clinical parameters including age, body mass index, prior abdominal surgery and biopsy grade group were similar across the 2 groups. No differences in estimated blood loss (169.2±114.2 vs 157.7±125.4 ml, p=0.64), operative time (255.9±44.1 vs 274.7±50.4 minutes, p=0.06), length of hospitalization (1.1±0.5 vs 1.4±1.1 days, p=0.17), rate of perioperative inpatient Clavien-Dindo complications 2 or greater (4.3% vs 6.3% p=0.66) and rate of positive pathological margin (21.3% vs 27.1%, p=0.51) were noted comparing the single-port and multi-port approaches, respectively.
The single-port robotic system allows a feasible approach to robot-assisted radical prostatectomy and has operative and perioperative outcomes comparable to those of the well accepted multi-port robotic approach.
由于微创手术的进步,根治性前列腺切除术的手术方法也在不断发展,目前大多数方法都涉及 Si 或 Xi 多端口机器人系统。美国食品和药物管理局批准了单端口达芬奇® SP 机器人平台,这导致了一些病例系列研究表明,对于前列腺癌患者,该平台用于机器人辅助根治性前列腺切除术具有安全性和可行性。然而,对于单端口与多端口机器人辅助根治性前列腺切除术相比,在围手术期结果方面尚无既定数据。
回顾性分析了我院 2 名泌尿外科医生于 2018 年 10 月至 2019 年 6 月期间施行的机器人辅助根治性前列腺切除术的所有患者。收集并使用 t 检验、卡方检验和 Fisher 精确检验统计方法分析了可获得的术前临床和人口统计学数据、手术参数和术后结果。
共有 95 例患者在我院接受了机器人辅助根治性前列腺切除术,其中 47 例为单端口,48 例为多端口。两组患者的术前临床参数(年龄、体重指数、既往腹部手术和活检分级组)相似。两组之间的估计失血量(169.2±114.2 与 157.7±125.4ml,p=0.64)、手术时间(255.9±44.1 与 274.7±50.4 分钟,p=0.06)、住院时间(1.1±0.5 与 1.4±1.1 天,p=0.17)、围手术期住院患者 Clavien-Dindo 并发症 2 级或以上的发生率(4.3%与 6.3%,p=0.66)以及阳性病理切缘的发生率(21.3%与 27.1%,p=0.51)均无差异。
单端口机器人系统为机器人辅助根治性前列腺切除术提供了一种可行的方法,其手术和围手术期结果与广泛接受的多端口机器人方法相当。